Is fenbendazole effective against all stages of cancer?

Pre-clinical and animal research involving fenbendazole, and other medications in the same drug class, have shown that these drugs have the potential to interfere with cancer metabolism and growth in a variety of ways.

Cancer cells, whether in an early stage of cancer or later stage, survive, grow and spread by common mechanisms.  These medications are considered experimental, and there are no human clinical trials that would potentially identify which types of cancer and at what stage these medications may be effective.

In addition, there are so many variables that influence a patient’s outcome, such as cancer type, aggressive phenotypes, overall health, lifestyle, and the organs/structures to which cancer has metastasized. 

There have been several Fenbendazole success stories involving late-stage cancers. Most famous is the account of Joe Tippens, who developed a protocol to reportedly cure himself from stage 4 lung cancer, with the guidance of a veterinarian friend.

Patients considering such treatments should consult with oncology specialists to understand the risks and benefits, ensuring any approach is safe and supported by available preclinical research.